ArticleInfectious diseases (London, England)2021

Immunobiology and nanotherapeutics of severe acute respiratory syndrome 2 (SARS-CoV-2): a current update.

Ifeanyi Elibe Mba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.